Biomarkers for Tinnitus: Key Proteins Analyzed

Serum levels of the outer hair cell protein prestin were significantly higher in people with chronic tinnitus than in matched controls, according to a new study published in *Otolaryngology–Head and Neck Surgery* (PMID: 42605968). This finding provides new support for the role of outer hair cell dysfunction in tinnitus and points to a potential future for objective biomarker testing.

### A Biomarker Search for an Invisible Condition

Tinnitus, the perception of sound without an external source, affects millions globally. Diagnosis and tracking of severity rely entirely on patient self-report through questionnaires like the Tinnitus Handicap Inventory (THI). The lack of an objective, biological measure has been a major obstacle in research and clinical management. A team led by Patrick Adamczyk at the University of Connecticut School of Medicine sought to change that by looking for evidence of inner ear activity in the bloodstream.

Their hypothesis centered on prestin, a protein exclusive to the outer hair cells (OHCs) of the cochlea. Prestin acts as a molecular motor, allowing these cells to amplify sound vibrations with incredible speed and precision. The researchers proposed that dysfunction or stress in these cells, potentially leading to their death or altered activity, could release prestin into the blood, making it a measurable signal.

To test this, they also measured serum levels of three other functionally important inner ear proteins: otoferlin (involved in neurotransmitter release at the inner hair cell synapse), connexin 26 (a gap junction protein critical for inner ear ion balance), and stereocilin (important for the structure of hair cell bundles). Comparing a panel of proteins allowed them to assess whether any changes were specific to tinnitus or more general markers of cochlear health.

### Measuring Proteins in a Matched Cohort

The study was an observational cohort design involving 82 participants at a tertiary academic center. Forty-one adults with chronic, bilateral, non-pulsatile tinnitus were carefully matched with 41 control subjects without tinnitus.

All participants underwent a standardized assessment. This included a full audiometric evaluation to measure hearing thresholds, a one-week personal noise dosimetry to quantify daily environmental noise exposure, and the THI to gauge tinnitus-related distress. Crucially, each participant also provided a blood sample via venipuncture.

The research team used enzyme-linked immunosorbent assays (ELISA) to precisely quantify the serum concentrations of the four target proteins. In their statistical analysis, they used a multivariate model to control for the potential confounding effects of age, hearing loss (particularly at high frequencies), and daily noise exposure—all factors that could independently influence inner ear health.

### Prestin Emerges as a Standout Signal

The results pointed clearly to one protein. Serum prestin levels were significantly higher in the tinnitus group compared to the control group, with a statistical significance of *P* = .006. This difference held strong even after the analysis accounted for age, hearing loss, and noise exposure (*P* = .003).

“The fact that prestin remained elevated after controlling for these key variables is important,” explains researcher Zana Preniqi. “It suggests the finding is specifically related to the presence of tinnitus, not just general hearing damage from age or noise.”

In contrast, serum levels of otoferlin, connexin 26, and stereocilin showed no significant difference between the tinnitus and control groups. Levels of connexin 26 and stereocilin did correlate with age and hearing thresholds, indicating they may be useful as general biomarkers of cochlear aging or function, but they did not distinguish tinnitus status.

An interesting secondary finding was a positive correlation between prestin and stereocilin levels across all subjects, which was stronger within the tinnitus group. This hints at a possible coordinated response or shared vulnerability of different hair cell structures in tinnitus. Notably, none of the protein levels correlated with THI scores, meaning higher biomarker levels did not predict greater self-reported distress. This disconnect between biological measure and subjective experience is common in brain and sensory disorders and requires further study.

### Implications for Research and Future Clinical Practice

This study provides direct biochemical evidence supporting the long-held theory that outer hair cells are involved in tinnitus generation. An elevated serum prestin level could indicate ongoing OHC stress, damage, or altered turnover in people with tinnitus, even when standard audiometry shows normal hearing thresholds.

For the research field, this finding is a step toward an objective biomarker. It could help in stratifying participants for clinical trials, ensuring that a “tinnitus” group has a common biological signature, and objectively measuring biological response to new treatments. You can read more about the ongoing search for objective measures in related conditions in our article on Hearing Loss Alters Brain Connectivity and Cognition.

Practically, a blood test for tinnitus is not imminent. This study needs replication in larger, more diverse populations. Future work must determine if prestin levels change with tinnitus severity over time or in response to effective management strategies. It also remains unknown if different tinnitus subtypes (e.g., tonal vs. broadband) have distinct biomarker profiles.

For patients and clinicians, the immediate implication is a strengthening of the biological basis for tinnitus. It moves the discussion further away from a purely psychological phenomenon and toward a sensorineural disorder. This can validate patient experiences and inform management approaches that target auditory system function, such as sound therapy. For insights into how sound-based strategies are applied, our resource on Sound Therapy Fitting and Verification Tips may be useful.

While the search for a simple diagnostic blood test continues, this research by Adamczyk and colleagues marks a clear advance. It identifies prestin as a promising candidate, focuses attention on the outer hair cell, and provides a new, measurable target for understanding the complex pathophysiology of tinnitus. For a broader look at how biomarker research is evolving, see our earlier article Biomarkers for Tinnitus: Prestin, Otoferlin, Connexin 26.